Patents Represented by Attorney William P. Ramey, III
-
Patent number: 6723324Abstract: The present invention provides a new antigenic type of chicken anaemia viruses (CAV). The CAV according to this invention is isolatable from turkeys in the field and its virulence for chickens is significantly reduced. This property makes these viruses particularly suited for preparing a live vaccine for protecting poultry against disease conditions resulting from CAV infection.Type: GrantFiled: February 27, 2001Date of Patent: April 20, 2004Assignee: Akzo Nobel NVInventors: Carla Christina Schrier, Henricus Johannes Maria Jagt
-
Patent number: 6682746Abstract: Disclosed herein is a serum-based adjuvanted vaccine which is substantially free of non-host albumin and the use thereof in reducing or preventing post-vaccination systemic reactions.Type: GrantFiled: March 14, 2002Date of Patent: January 27, 2004Inventors: Kristina J. Hennessy, Karen K. Brown, Jennifer K. Lane, Sandra L. Trump
-
Patent number: 6635679Abstract: The present invention relates to methods and processes of inactivating a viral contaminants in a biological source material or process intermediate by contacting the biological source material (e.g., a host cell, cell supernatant, cell lysate, blood plasma, tissue homogenate, or other biological materials) with a solution containing one or more alkylamine compounds. In a particular embodiment, the active ingredients are amphipathic, charged amines or amine oxides coupled to saturated hydrocarbon chains of varying lengths.Type: GrantFiled: May 14, 2001Date of Patent: October 21, 2003Assignee: Akzo Nobel N.V.Inventor: Scot R. Shepard
-
Patent number: 6585978Abstract: The invention provides an equine infectious anemia (EIA) vaccine that provides immunity to mammals, especially equines, from infection with equine infectious anemia virus (EIAV) and which allows differentiation between vaccinated and non-vaccinated, but exposed, mammals or equines. Preferably said vaccine encompasses at least one mutation in an EIAV which produces a non-functional gene in the vaccine virus that is always expressed in disease-producing wild-type EIA viruses. Additionally, said EIA vaccine virus cannot cause clinical disease in mammals or spread or shed to other mammals including equines.Type: GrantFiled: September 9, 2000Date of Patent: July 1, 2003Assignee: Akzo NobelInventors: Ronald Montelaro, Bridget Puffer, Feng Li, Charles Issel, Kristina J. Hennessy, Karen K. Brown
-
Patent number: 6569422Abstract: The present invention relates to a method for the adaptation of infectious bursal disease viruses (IBDV) to growth in CEF cell culture. Changing the codons for amino acid residues 253 (Gln) and 284 (Ala) to 253 (His) and 284 (Thr) allowed bursa adapted Classical and Variant-E IBDV to grow in CEF cell culture. For GLS IBDV only a change of the codon for amino acid residue 284 was necessary.Type: GrantFiled: July 10, 2002Date of Patent: May 27, 2003Assignee: Akzo Nobel N.V.Inventors: Adriaan Antonius Wilhelmus Maria van Loon, Egbert Mundt
-
Patent number: 6541465Abstract: Novel, orally active androgens are 7&agr;-substituted &Dgr;14-nandrolone derivatives. The compounds satisfy the general formula: wherein R1 is O, (H,H), (H,OR), NOR, with R being hydrogen, (C1-6) alkyl, or (C1-6) acyl; R2 is selected from the group consisting of (C2-4) alkyl, (C2-4) alkenyl, or (C2-4) alkynyl, each optionally substituted by halogen; or R2 is cyclopropyl, or cyclopropenyl, each optionally substituted by (C1-2) alkyl, or halogen; R3 is hydrogen, (C1-2) alkyl, or ethenyl; R4 is (C1-2) alkyl; R5 is hydrogen, or (C1-15) acyl; and the dotted lines indicate optional bonds.Type: GrantFiled: July 31, 2001Date of Patent: April 1, 2003Assignee: Akzo Nobel N.V.Inventors: Hubert Jan Jozef Loozen, Dirk Leysen, Jaap van der Louw
-
Patent number: 6528250Abstract: The invention relates to a method for infecting equines with an equine infectious anemia virus (EIAV) in order to reproduce a natural infection challenge model. More specifically, the invention provides a multiple low dose equine EIA challenge model comprising administering at least 1 median horse infective dose to an equine using an intravenous route of administration. It is preferable that the EIAV be administered on a repeated basis. The multiple low dose EIA challenge model described herein can be used for testing efficacy of vaccines, treatments and diagnostic tests.Type: GrantFiled: September 9, 2000Date of Patent: March 4, 2003Assignee: Akzo Nobel N.V.Inventors: Ronald Montelaro, Bridget Puffer, Feng Li, Charles Issel, Kristina J. Hennessey, Karen K. Brown
-
Patent number: 6498184Abstract: The present invention relates to a method of treatment of hot flushes with a 5-HT2c receptor agonist and in particular to the use of the selective 5-HT2C receptor agonists 1-[6-chloro-5-(trifluoromethyl)-2-pyridinyl]-piperazine and (S)-(+)-3-[(2,3-dihydro-5-methoxy-1H-inden-4-yl)oxy-pyrrolidine or pharmaceutically acceptable acid addition salts thereof for the manufacture of a pharmaceutical formulation adapted for the treatment of hot flushes.Type: GrantFiled: October 29, 2001Date of Patent: December 24, 2002Assignee: Akzo Nobel N.V.Inventor: Hermanus Henricus Gerardus Berendsen
-
Patent number: 6492148Abstract: The present invention relates to a method for the adaptation of infectious bursal disease viruses (IBDV) to growth in CEF cell culture. Changing the codons for amino acid residues 253 (Gln) and 284 (Ala) to 253 (His) and 284 (Thr) allowed bursa adapted Classical and Variant-E IBDV to grow in CEF cell culture. For GLS IBDV only a change of the codon for amino acid residue 284 was necessary.Type: GrantFiled: February 25, 2000Date of Patent: December 10, 2002Assignee: Akzo Nobel NVInventors: Adriaan Antonius Wilhelmus Maria van Loon, Egbert Mundt
-
Patent number: 6485940Abstract: The present invention provides a broad spectrum IBDV vaccine that is able to induce a protective immune response against classical- and variant E IBDV strains. Moreover, the vaccine can be administered to poultry by mass application routes.Type: GrantFiled: June 25, 2001Date of Patent: November 26, 2002Assignee: Akzo Nobel N.V.Inventors: Egbert Mundt, Adriaan Antonius Wilhelmus Maria Loon Van
-
Patent number: 6486354Abstract: Embodiments of the present invention generally relate to carrying out organic chemistry on solid supports comprising derivatised functionalities, methods for synthesizing said supports, methods for synthesizing compounds comprising amine groups or N-containing heterocycles using said solid supports, intermediate compounds linked to said supports and uses thereof.Type: GrantFiled: April 17, 2000Date of Patent: November 26, 2002Assignee: Akzo Nobel N.V.Inventors: David Gani, Friedrich Erich Karl Kroll, Michael John Plater, John Richard Morphy, David Rees
-
Patent number: 6461616Abstract: Disclosed herein is a vaccine which provides immunity to mammals from infection and/or disease caused by a lentivirus, such as equine infectious anemia virus, human immunodeficiency virus (HIV), feline immunodeficiency virus (FIV), bovine immunodeficiency virus (BIV) or simian immunodeficiency virus (SIV) said composition comprising a deletion in a gene that blocks replication of the virus in vivo. Preferably said composition encompasses at least one deletion in a lentivirus which provides protection from exposure to wild-type lentiviruses. It also encompasses a marker vaccine in which a foreign gene is inserted into the gene-deleted region, said inserted gene providing a diagnostic tool for use in vaccinated mammals. The scope of the invention encompasses an EIAV vaccine that allows equines to be safely vaccinated and protected from disease without converting to a seropositive status on the Coggin's Test or any other test which measures p26.Type: GrantFiled: September 9, 2000Date of Patent: October 8, 2002Assignee: Akzo Nobel NVInventors: Ronald Montelaro, Jodi Craigo, Charles Issel, Bridget Puffer, Kristina J. Hennessy, Karen K Brown
-
Patent number: 6458363Abstract: The present invention is directed to a method to prepare an inactivated w/o emulsion adjuvated vaccine, wherein an aqueous solution comprising one or more inactivated angigens is mixed under mild conditions with a ready-made w/o emulsion. Preferably the vaccine is prepared just prior to vaccination. The aqueous solution and w/o emulsion are stirred or shaken by mechanical means or by hand. The present invention also relates to a kit of parts for use in a method according to the invention.Type: GrantFiled: June 21, 2001Date of Patent: October 1, 2002Assignee: Akzo Nobel N.V.Inventors: Carla Christina Schrier, Eric Onno Rijke
-
Patent number: 6451321Abstract: The present invention provides a novel infectious bursal disease virus, strain 689 which is suited as vaccine candidate for in ovo vaccination and is deposited at the European Collection of Cell Cultures, Salisbury, Wiltshine, United Kingdom under No. V00012609.Type: GrantFiled: June 8, 2001Date of Patent: September 17, 2002Assignee: Akzo Nobel N.V.Inventors: Egbert Mundt, Adriaan Antonius Wilhelmus Maria Loon Van
-
Patent number: 6437101Abstract: Methods are provided in this invention for the isolation of human growth hormone, growth hormone antagonist, or a homologue of either, from a biological source. The methods of the invention use multi-phase extraction.Type: GrantFiled: May 7, 1999Date of Patent: August 20, 2002Assignee: Akzo Nobel N.V.Inventors: Kirk James Hayenga, Pascal P. Valex
-
Patent number: 6425879Abstract: The present invention relates to a needle-less injector having a housing comprising: a chamber defined within said injector for containing liquid to be injected; a liquid outlet for said chamber positioned at the front end of the injector; a dispensing member in contact with the liquid in said chamber and movable in a first direction to reduce the volume of said chamber to cause the liquid contained therein to be expelled through said liquid outlet; an impacting member arranged to strike said dispensing member to cause movement thereof in said first direction; drive means connected to the impacting member for actuating said injector, or permitting actuation thereof, in response to the application of a selected amount of axial pressure, characterized in that the housing is essentially unitary and the chamber, the liquid outlet and the drive means are immobile with respect to the housing, and that the injector comprises a pressure sensor in order to sense the axial pressure, which pressure sensor is connected tType: GrantFiled: May 10, 1999Date of Patent: July 30, 2002Assignee: Akzo Nobel N.V.Inventors: Willi Egger, Nicolaas Visser, Antonie Hendrikus Meijering
-
Patent number: 6413532Abstract: A repellent solid pest control system which includes a polymeric matrix, a liquid plasticizer, a pest control active ingredient and triphenyl phosphate as a carrier for the active ingredient. Protection of dogs from bites of phlebotomine sandflies by using systems according to the inventor for the control of canine leishmaniasis.Type: GrantFiled: October 3, 2000Date of Patent: July 2, 2002Assignee: Akzo Nobel N.V.Inventors: Catherine Focheux, Marie Pierre Puech, Robert Killick-Kendrick, Mireille Killick-Kendrick
-
Patent number: 6357470Abstract: A packer joint is provided for mounting on a vessel or pipeline entry valve which includes a stinger guide and seal. Clamping collet are mounted within the packer to retain the stinger in the desired position. Different metals within the guide body from those of the stinger rod prevent gaulding and damage. A lock-up the rod may be released via a bore hole providing tapping access to the collets.Type: GrantFiled: June 7, 2000Date of Patent: March 19, 2002Assignee: Accurate Tool CompanyInventors: Willie V. Evans, Gary K. Evans
-
Patent number: 6328053Abstract: A system for filing or discharging compressed gas or liquid cylinders mounted on the cylinder. An automatic system for filing or discharging a compressed gas cylinder, specifically chlorine, sulfur dioxide, or ammonia cylinders. The system includes an electric motor that rotates the cylinder valve system toward open or closed position without interfering with or requiring additional adapters for the filing or discharge hardware. The motor, gears, and controls are assembled as one unit to eliminate the necessity for a separate control panel or interconnecting control wires. The system has the capabilities for integral leak detection with automatic shutdown, battery backup in the event of power failure, remote control by leak detector, remote control panic button, remote low weight transmitter, remote vacuum switch for automatic switch-over systems and other remote digital signals.Type: GrantFiled: September 1, 1999Date of Patent: December 11, 2001Inventor: Gary Slaydon